Table 2.
PERSEVERE test characteristics across the study cohorts.
| ALL SUBJECTS | TAMOF | MOF | NO MOF | |
|---|---|---|---|---|
| N | 660 | 209 | 290 | 161 |
|
| ||||
| False Positive | 151 | 57 | 77 | 17 |
| True Positive | 72 | 43 | 29 | 0 |
| True Negative | 424 | 105 | 175 | 144 |
| False Negative | 13 | 4 | 9 | 0 |
|
| ||||
| Sensitivity | 85 (75 – 91) | 91 (79 – 97) | 76 (59 – 88) | -- |
| Specificity | 74 (70 – 77) | 65 (57 – 72) | 69 (58 – 69) | -- |
|
| ||||
| PPV | 32 (26 – 39) | 43 (33 – 53) | 27 (19 – 37) | -- |
| NPV | 97 (95 – 98) | 96 (90 – 99) | 95 (91 – 98) | -- |
|
| ||||
| +LR | 3.2 (2.7 – 3.8) | 2.6 (2.1 – 3.3) | 2.5 (1.9 – 3.2) | -- |
| −LR | 0.2 (0.1 – 0.3) | 0.1 (0.05 – 0.3) | 0.3 (0.2 – 0.6) | -- |
|
| ||||
| AUC | 0.80 (0.75 – 0.86) | 0.84 (0.77 – 0.90) | 0.71 (0.61 – 0.80) | -- |